<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35090015</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1537-6591</ISSN><JournalIssue CitedMedium="Internet"><Volume>75</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>24</Day></PubDate></JournalIssue><Title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</Title><ISOAbbreviation>Clin Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Symptoms Compatible With Long Coronavirus Disease (COVID) in Healthcare Workers With and Without Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-Results of a Prospective Multicenter Cohort.</ArticleTitle><Pagination><StartPage>e1011</StartPage><EndPage>e1019</EndPage><MedlinePgn>e1011-e1019</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/cid/ciac054</ELocationID><Abstract><AbstractText Label="BACKGROUND">The burden of long-term symptoms (ie, long COVID) in patients after mild COVID-19 is debated. Within a cohort of healthcare workers (HCWs), frequency and risk factors for symptoms compatible with long COVID are assessed.</AbstractText><AbstractText Label="METHODS">Participants answered baseline (August/September 2020) and weekly questionnaires on SARS-CoV-2 nasopharyngeal swab (NPS) results and acute disease symptoms. In January 2021, SARS-CoV-2 serology was performed; in March, symptoms compatible with long COVID (including psychometric scores) were asked and compared between HCWs with positive NPS, seropositive HCWs without positive NPS (presumable asymptomatic/pauci-symptomatic infections), and negative controls. The effect of time since diagnosis and quantitative anti-spike protein antibodies (anti-S) was evaluated. Poisson regression was used to identify risk factors for symptom occurrence.</AbstractText><AbstractText Label="RESULTS">Of 3334 HCWs (median, 41 years; 80% female), 556 (17%) had a positive NPS and 228 (7%) were only seropositive. HCWs with positive NPS more frequently reported &#x2265;1 symptom compared with controls (73% vs 52%, P&#x2005;&lt;&#x2005;.001); seropositive HCWs without positive NPS did not score higher than controls (58% vs 52%, P&#x2005;=&#x2005;.13), although impaired taste/olfaction (16% vs 6%, P&#x2005;&lt;&#x2005;.001) and hair loss (17% vs 10%, P&#x2005;=&#x2005;.004) were more common. Exhaustion/burnout was reported by 24% of negative controls. Many symptoms remained elevated in those diagnosed &gt;6 months ago; anti-S titers correlated with high symptom scores. Acute viral symptoms in weekly questionnaires best predicted long-COVID symptoms. Physical activity at baseline was negatively associated with neurocognitive impairment and fatigue scores.</AbstractText><AbstractText Label="CONCLUSIONS">Seropositive HCWs without positive NPS are only mildly affected by long COVID. Exhaustion/burnout is common, even in noninfected HCWs. Physical activity might be protective against neurocognitive impairment/fatigue symptoms after COVID-19.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Strahm</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1713-262X</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seneghini</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;sewell</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egger</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leal-Neto</LastName><ForeName>Onicio</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Epitrack, Recife, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Economics, University of Zurich, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brucher</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Psychiatry Services of the Canton of St Gallen (South), St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemmenmeier</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Clienia Littenheid AG, Private Clinic for Psychiatry and Psychotherapy, Littenheid, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier Kleeb</LastName><ForeName>Dorette</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Occupational Health, Kantonsspital Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf6;ller</LastName><ForeName>J Carsten</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Center for Neurological Rehabilitation, Zihlschlacht, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rieder</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hirslanden Clinic, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruetti</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fuerstenland Toggenburg Hospital Group, Wil, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rutz</LastName><ForeName>Remus</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Hans Ruedi</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Central Laboratory, Kantonsspital Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stocker</LastName><ForeName>Reto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hirslanden Clinic, Zurich, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuichard-Gysin</LastName><ForeName>Danielle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Thurgau Hospital Group, Muensterlingen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiggli</LastName><ForeName>Benedikt</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Besold</LastName><ForeName>Ulrike</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Geriatric Clinic St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kuster</LastName><ForeName>Stefan P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Federal Office of Public Health, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McGeer</LastName><ForeName>Allison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Sinai Health System, Toronto, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Risch</LastName><ForeName>Lorenz</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Labormedizinisches Zentrum Dr Risch Ostschweiz AG, Buchs, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Private Universit&#xe4;t im F&#xfc;rstentum Liechtenstein, Triesen, Liechtenstein.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Laboratory Medicine, Institute of Clinical Chemistry, University of Bern, Inselspital, Bern, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Friedl</LastName><ForeName>Andr&#xe9;e</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Kantonsspital Baden, Baden, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schlegel</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmid</LastName><ForeName>Dagmar</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Clinic for Psychosomatic and Consultation Psychiatry, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vernazza</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahlert</LastName><ForeName>Christian R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kohler</LastName><ForeName>Philipp</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-0427-8934</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St Gallen, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Infect Dis</MedlineTA><NlmUniqueID>9203213</NlmUniqueID><ISSNLinking>1058-4838</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D058345" MajorTopicYN="N">Asymptomatic Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000857" MajorTopicYN="Y">Olfaction Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">asymptomatic</Keyword><Keyword MajorTopicYN="N">healthcare workers</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">serology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>28</Day><Hour>17</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35090015</ArticleId><ArticleId IdType="pmc">PMC9383387</ArticleId><ArticleId IdType="doi">10.1093/cid/ciac054</ArticleId><ArticleId IdType="pii">6516835</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021; 27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva Andrade B, Siqueira S, de Assis Soares WR, et al. . Long-COVID and post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses 2021; 13:700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8072585</ArticleId><ArticleId IdType="pubmed">33919537</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB.. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol 2021; 12:698169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ayoubkhani D.
Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021. Accessed 22 July 2021.</Citation></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med 2021; 92:55&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021; 27:626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Y G, Heath K, et al. . Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 2021; 373:n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021; 38:101019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E, van Willigen HDG, Dijkstra M, et al. . Evolution of COVID-19 symptoms during the first 12 months after illness onset. Clin Infect Dis 2021. doi: 10.1093/cid/ciab759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab759</ArticleId><ArticleId IdType="pmc">PMC8522402</ArticleId><ArticleId IdType="pubmed">34473245</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508&#xa0;707 people. medRxiv, doi: 10.1101/2021.06.28.21259452, 2021, preprint: not peer reviewed.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J, Ma S, Wang Y, et al. . Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open 2020; 3:e203976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7090843</ArticleId><ArticleId IdType="pubmed">32202646</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn KG, Brokstad KA, et al. . Long COVID in a prospective cohort of home-isolated patients. Nat Med 2021; 27:1607&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Kahlert CR, Persi R, Gusewell S, et al. . Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers&#x2014;a multicentre cross-sectiona l study. Clin Microbiol Infect 2021; 27:1336&#x2013;44. doi: 10.1101/2020.11.10.20229005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.11.10.20229005</ArticleId><ArticleId IdType="pmc">PMC8131187</ArticleId><ArticleId IdType="pubmed">34020033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohler P, G&#xfc;sewell S, Seneghini M, et al. . Impact of baseline SARS-CoV-2 antibody status on syndromic surveillance and the risk of subsequent COVID-19&#x2014;a prospective multicenter cohort study. BMC Med 2021; 19:270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8514323</ArticleId><ArticleId IdType="pubmed">34649585</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN.. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open 2021; 4:e2111417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ.. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 2021; 57. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Cuadrado ML, Florencio LL.. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health 2021; 18. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Crameri GAG, Bielecki M, Zust R, Buehrer TW, Stanga Z, Deuel JW.. Reduced maximal aerobic capacity after COVID-19 in young adult recruits, Switzerland, May 2020. Euro Surveill 2020; 25. doi: 10.2807/1560-7917.ES.2020.25.36.2001542.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.36.2001542</ArticleId><ArticleId IdType="pmc">PMC7502899</ArticleId><ArticleId IdType="pubmed">32914744</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, et al. . Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect 2021; 27:1507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Kollndorfer K, Reichert JL, Bruckler B, Hinterleitner V, Schopf V.. Self-esteem as an important factor in quality of life and depressive symptoms in anosmia: a pilot study. Clin Otolaryngol 2017; 42:1229&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5724690</ArticleId><ArticleId IdType="pubmed">28236363</ArticleId></ArticleIdList></Reference><Reference><Citation>Croy I, Nordin S, Hummel T.. Olfactory disorders and quality of life&#x2014;an updated review. Chem Senses 2014; 39:185&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">24429163</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021; 27:89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. . More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep 2021; 11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Arrones OM, Lobato-Berezo A, Gomez-Zubiaur A, et al. . SARS-CoV-2-induced telogen effluvium: a multicentric study. J Eur Acad Dermatol Venereol 2021; 35:e181&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753386</ArticleId><ArticleId IdType="pubmed">33220124</ArticleId></ArticleIdList></Reference><Reference><Citation>P S, Wang M, Song T, et al. . The psychological impact of COVID-19 pandemic on health care workers: a systematic review and meta-analysis. Front Psychol 2021; 12:626547.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8297953</ArticleId><ArticleId IdType="pubmed">34305703</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgantini LA, Naha U, Wang H, et al. . Factors contributing to healthcare professional burnout during the COVID-19 pandemic: a rapid turnaround global survey. PLoS One 2020; 15:e0238217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7470306</ArticleId><ArticleId IdType="pubmed">32881887</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Beltran WF, Lam EC, Astudillo MG, et al. . COVID-19-neutralizing antibodies predict disease severity and survival. Cell 2021; 184:476&#x2013;88, e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837114</ArticleId><ArticleId IdType="pubmed">33412089</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Covid-19: Two antibody tests are &#x201c;highly specific&#x201d; but vary in sensitivity, evaluations find. BMJ 2020; 369:m2066.</Citation><ArticleIdList><ArticleId IdType="pubmed">32439655</ArticleId></ArticleIdList></Reference><Reference><Citation>Piedimonte G. Respiratory syncytial virus and asthma: speed-dating or long-term relationship?. Curr Opin Pediatr 2013; 25:344&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3889210</ArticleId><ArticleId IdType="pubmed">23657245</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnus P, Gunnes N, Tveito K, et al. . Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine 2015; 33:6173&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26475444</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen I, Thomas JM, Hamilton WT, White PD.. Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. QJM 2006; 99:49&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">16330509</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ.. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273&#xa0;618 survivors of COVID-19. PLoS Med 2021; 18:e1003773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B.. High-dimensional characterization of post-acute sequelae of COVID-19. Nature 2021; 594:259&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. . Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg Health Eur 2021; 8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Milne A, Samms E, Stadon L, Maskell NA, Hamilton FW.. Symptoms after COVID-19 vaccination in patients with persistent symptoms after acute infection: a case series. Ann Intern Med 2021; 174:1335&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8252827</ArticleId><ArticleId IdType="pubmed">34029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. . Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis 2022; 22:43&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence. 
COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): evidence review 5: interventions. NICE Guideline, No. 188. London: National Institute for Health and Care Excellence (UK), 2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK567264/. Accessed 13 October 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555764</ArticleId></ArticleIdList></Reference><Reference><Citation>F Bu, Bone JK, Mitchell JJ, Steptoe A, Fancourt D.. Longitudinal changes in physical activity during and after the first national lockdown due to the COVID-19 pandemic in England. Sci Rep 2021; 11:17723.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8413348</ArticleId><ArticleId IdType="pubmed">34475465</ArticleId></ArticleIdList></Reference><Reference><Citation>Wajnberg A, Amanat F, Firpo A, et al. . Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science 2020; 370:1227&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7810037</ArticleId><ArticleId IdType="pubmed">33115920</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P.. Long Covid&#x2014;mechanisms, risk factors, and management. BMJ 2021; 374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>